Embiosys Diagnostics & Molecular Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 22.18%
- Profit Growth 46.74%
- Ebitda -5.52%
- Net Worth 13.84%
- Total Assets 10.83%
About Embiosys Diagnostics & Molecular Research
Embiosys Diagnostics & Molecular Research Private Limited (EDMRPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 April 2013 and has a history of 11 years and nine months. Its registered office is in Guntur, Andhra Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jagarlamudi Rao, Potini Venkata, Kodanda Bodduluru, and Four other members serve as directors at the Company.
Company Details
-
Location
Guntur, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100AP2013PTC087027
-
Company No.
087027
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Apr 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Embiosys Diagnostics & Molecular Research?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagarlamudi Rao
|
Director | 22-Apr-2013 | Current |
|
Potini Venkata
|
Director | 17-Apr-2013 | Current |
|
Kodanda Bodduluru
|
Director | 22-Apr-2013 | Current |
|
Dinakara Koganti
|
Director | 22-Apr-2013 | Current |
|
Kusumakumari Kanamarlapudi
|
Director | 22-Apr-2013 | Current |
|
Ramesh Puttagunta
|
Director | 17-Apr-2013 | Current |
Financial Performance of Embiosys Diagnostics & Molecular Research.
Embiosys Diagnostics & Molecular Research Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 22.18% increase. The company also saw a substantial improvement in profitability, with a 46.74% increase in profit. The company's net worth Soared by an impressive increase of 13.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Embiosys Diagnostics & Molecular Research?
In 2017, Embiosys Diagnostics & Molecular Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vivan Bioelegants Private LimitedJagarlamudi Rao is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Embiosys Diagnostics & Molecular Research?
Unlock and access historical data on people associated with Embiosys Diagnostics & Molecular Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Embiosys Diagnostics & Molecular Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Embiosys Diagnostics & Molecular Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
